Randomized, Double-Blind, Placebo-Controlled First-in-Human Trial of a First-in-Class AI-Designed Monoclonal Antibody (GB-0669) Against the Conserved SARS-CoV-2 Spike S2 Stem Helix. (academic.oup.com)

Authors: Borriello F … De Alwis DP Journal: Journal of Infectious Diseases Published: 2026-07-14 DOI: https://doi.org/10.1093/infdis/jiag349